July 07, 2020
As per the report titled ‘Global Assisted Reproductive Technology (ART) Market - Analysis By Technology, Products, End User, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2020-2025)’, available with Market Study Report LLC, global assisted reproductive technology (ART) market was valued at USD 24,133.23 million in the year 2019, and is expected to record remunerative growth over 2020-2025.
Increasing stress and pollution levels, growing consumption of alcohol and cigarettes are driving the growth of global assisted reproductive technology (ART) market. Also, acceptance of homosexual couples and increasing number of single mothers are further anticipated to enhance the market scenario over the projected period.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2515100/
Vitro fertilization technique is popular owing to its high success rate for embryo transfer and increase in live birth rates. Drugs like orals and hormones are used widely to prepare individuals for ART treatment. Also, development of In vivo ART devices by INVOcell and Anecova are slated to catalyze the market growth.
Geographically, Asia-Pacific is poised to hold the largest fragment of the market owing to decreased male and female fertility. Europe and America are slated to follow Asia-Pacific in terms of market share.
Monash IVF Group, INVO Bioscience, Merck, Cooper Surgical, Hamilton Thorne, Anecova, Nidacon International AB, Esco, and Irvine Scientific among others are the major companies operating in global assisted reproductive technology (ART) market.